Joint Statement on Universal Health Coverage and TB Research
Joint Statement for Multi-stakeholder Hearing on UHC: Product Development Partnerships “We face a collective challenge in ensuring that everyone—regardless where
A Conversation with Karl Hofmann
We spoke with Karl Hofmann, president and CEO of Population Services International (PSI), to hear about his time serving as
TB Alliance and Mylan Announce Global Collaboration to Commercialize Investigational Drug Pretomanid as Part of Two Regimens to Treat Tuberculosis
NEW YORK, HERTFORDSHIRE, England and PITTSBURGH – April 18, 2019 – Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan
Statement on Building a Tuberculosis Free World: The Lancet Commission on Tuberculosis
March 20, 2019 – Building a Tuberculosis Free World: The Lancet Commission on Tuberculosis, released today, outlines what is needed
TB Medicine Pretomanid Enters Regulatory Review Process in the United States
NEW YORK, NY (March 8, 2019)—TB Alliance’s new drug application (NDA) for the novel tuberculosis (TB) drug candidate pretomanid has
Compound Studied in TB to be Evaluated in the Treatment of Leishmaniasis
NEW YORK (February 5, 2019) – TB Alliance applauds the Wellcome Trust’s commitment of over £10 million to the Drugs
Increased Commitment to Neglected Disease R&D, but TB Landscape Remains Largely Unchanged
January 23, 2019 – The 2018 G-FINDER report shows that while funding for tuberculosis (TB) research and development (R&D) reached
Played Red Dead Redemption 2? Here’s what you should know about TB
Please note: this article discusses a major plot point of Red Dead Redemption 2 For players of Red Dead Redemption
Jan Lundberg Joins TB Alliance Board of Directors
NEW YORK (January 15, 2019)—TB Alliance, a not-for-profit organization dedicated to developing new drug regimens to fight tuberculosis (TB), has
Schrödinger and TB Alliance Announce Collaboration to Accelerate Tuberculosis Drug Discovery
NEW YORK – Dec. 11, 2018 – Schrödinger and TB Alliance today announced a three-year research collaboration to speed the